AKT1 and Alzheimer disease: Therefore, targeting and modulating the PI3K/AKT pathway activities and its downstream phosphorylated substrates have been proposed as a reasonable approach to confer neuroprotection and represent a common target of TCMs' beneficial effect in the treatment of AD [175, 179].